Exoskeletons for Cerebral Palsy: A Promise Yet to Be Fully Realized
Cerebral palsy, a lifelong condition affecting around 50 million people worldwide, presents a myriad of challenges, particularly in mobility and movement. While traditional physiotherapy has been a cornerstone of management, the advent of exoskeletons has introduced a new dimension to rehabilitation.
Exoskeletons, those wearable devices that support the body from the outside, have shown promise in improving posture and movement. However, the journey from the lab to everyday life is fraught with questions and uncertainties.
The Promise of Exoskeletons
The concept of exoskeletons isn't new. The first devices designed to assist walking were developed in the 1960s, but they were clunky and complex, taking decades to leave the lab. Over the past 60 years, these devices have become more streamlined, with several approved by Australia's Therapeutic Goods Administration in recent years.
There are three main categories of medical exoskeletons. Two are static, paired with treadmills or elliptical machines, while the third category includes overground devices like the Atlas 2030, offering users more flexibility and interaction with their environment.
The Evidence
A recent systematic review, published in the Disability and Rehabilitation Journal, examined the effects of wearable overground exoskeleton-assisted therapy on physical, functional, quality of life, and participatory domains for people with cerebral palsy. The review included 21 studies representing 241 participants, with an average age of nine.
The findings were encouraging, with robotic rehabilitation outperforming conventional therapies in four key areas: walking speed, walking endurance, balance, and high-level mobility. This suggests that exoskeletons could provide meaningful benefits in these areas for individuals with cerebral palsy.
However, the review also highlighted several limitations. Very few studies re-evaluated outcomes after therapy cessation, making it difficult to determine the sustainability of benefits. The inability to categorize results by type or severity of cerebral palsy, or by age, further complicates the application of findings.
Moreover, the review did not explicitly compare exoskeleton therapy with the next most equivalent and readily available intervention, bodyweight-supported treadmill training, leaving a gap in the evidence base.
The Cost and Accessibility
The rising availability of overground exoskeleton therapy in Australia, supported by NDIS funding, presents a unique challenge. While families are eager to explore new and exciting therapy options, the cost and accessibility of these sessions can be a barrier. Additionally, the lack of funding schemes for personal exoskeletons raises concerns about the equitable distribution of this technology.
The Way Forward
As exoskeletons become more prevalent in cerebral palsy rehabilitation, it is crucial for clinicians to provide evidence-based advice. They should set clear goals for what results to expect and proceed with caution. The promise of exoskeletons is real, but it is a promise yet to be fully realized. The journey from promise to practice requires careful consideration and ongoing research.
In conclusion, while exoskeletons offer exciting possibilities for cerebral palsy management, the path to widespread adoption is paved with questions and uncertainties. It is up to researchers, clinicians, and policymakers to navigate this path, ensuring that the promise of exoskeletons becomes a reality for those who need it most.
